Recruiting
The Effect of Coconut Oil on Alopecia
İn this study will be conducted to evaluate the effect of coconut oil on alopecia in 86 female breast cancer patients treated at Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital between 01.02.2025-31.12.2025.
ClinicalTrials.gov IDNCT06818370
PhaseNA
Enrollment86
SponsorDr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
Age18 Years – 65 Years
SexFEMALE
Conditions studied
Breast Cancer
About this study
İn this study will be conducted to evaluate the effect of coconut oil on alopecia in 86 female breast cancer patients treated at Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital between 01.02.2025-31.12.2025.
Interventions
- Other: Coconut Oil — The coconut oil application protocol will be explained to the patients in the experimental group and 10 milliliters of coconut oil will be applied to the hair follicles once a week. Alopecia assessment will be done every week.
Primary outcomes
- National Cancer Instute (NCI) Common Terminology Criteria for Adverse Events (CTCAE); Alopecia (1-12 WEEK)
Eligibility information
Inclusion Criteria:
* • To have been diagnosed with breast cancer.
* The chemotherapy treatment plan should be planned as the Doxorubicin-Cyclophosphamide protocol.
* Volunteer to participate in the study.
* Be 18 years of age or older.
* Being a woman.
Exclusion Criteria:
* • Having any health problem or disability that prevents communication (vision-hearing problems, neurological, psychiatric diseases).
* Planning other treatments other than the Doxorubicin-Cyclophosphamide protocol for the treatment of breast cancer.
* Not volunteering to participate in the study.
* Having previously experienced any disease/skin problem that causes hair loss.
* Having received chemotherapy before.
Study locations
- Dr. Abdurrahman Yurtaslan Ankara Onkoloji Eğitim ve Araştırma Hastanesi, Ankara, Yenimahalle 06170 Turkey (Türkiye)
Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-11-18.